Tiffany Hsu

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 22 papers. Top paper: “Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot‘”.

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot‘

Annals of the Rheumatic Diseases(2020)10.1136/annrheumdis-2020-217888

N/A

0.846DataRank · unranked

280 citations

Naomi Serling‐Boyd, Rachel Wallwork, Tiffany Hsu, Xiaoqing Fu, Ellen M. Gravallese +4 more

Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer

Cell(2021)10.1016/j.cell.2020.12.031

N/A

0.814DataRank · unranked

227 citations

Jarey H. Wang, Fade Gong, William Wu, Nicholas J. Neill, Ik Sun Kim +32 more

Association of Race and Ethnicity With COVID‐19 Outcomes in Rheumatic Disease: Data From the COVID‐19 Global Rheumatology Alliance Physician Registry

Arthritis & Rheumatology(2020)10.1002/art.41567

N/A

0.683DataRank · unranked

94 citations

Liza Leykina, Zara Izadi, Tiffany Taylor, Jeffrey A. Sparks, Carly Harrison +23 more

Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance

Annals of the Rheumatic Diseases(2022)10.1136/annrheumdis-2021-221636

N/A

0.680DataRank · unranked

92 citations

Graciela S. Alarcón, Zara Izadi, Alí Duarte‐García, Cristina Reátegui-Sokolova, Ann E. Clarke +53 more

Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study

The Lancet Rheumatology(2021)10.1016/s2665-9913(21)00140-5

N/A

0.550DataRank · unranked

38 citations

Kristin M. D’Silva, Naomi J. Patel, Jiaqi Wang, Alisa A. Mueller, Xiaoqing Fu +11 more

Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave

Annals of the Rheumatic Diseases(2022)10.1136/ard-2022-222954

N/A

0.538DataRank · unranked

35 citations

Naomi J. Patel, Xiaosong Wang, Claire Cook, Kathleen M.M. Vanni, Emily Kowalski +9 more

Incident systemic rheumatic disease following COVID-19

The Lancet Rheumatology(2021)10.1016/s2665-9913(21)00106-5

N/A

0.489DataRank · unranked

25 citations

Kristin M. D’Silva, Naomi J. Patel, Xiaoqing Fu, Zachary S. Wallace, Jeffrey A. Sparks +1 more

Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

The Lancet Rheumatology(2022)10.1016/s2665-9913(22)00192-8

N/A

0.449DataRank · unranked

19 citations

Milena Gianfrancesco, Gabriela Schmajuk, Lindsay Jacobsohn, Patricia Katz, Stephanie Rush +91 more

COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort Study

medRxiv(2021)10.1101/2021.08.05.21261643

N/A

0.330DataRank · unranked

8 citations

Kristin M. D’Silva, Tiffany Hsu, Michael DiIorio, Xiaoqing Fu, Claire Cook +8 more

DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study

medRxiv(2022)10.1101/2022.02.08.22270696

N/A

0.292DataRank · unranked

6 citations

Claire Cook, Kathleen M.M. Vanni, Naomi J. Patel, Kristin M. D’Silva, Xiaoqing Fu +10 more

Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron

medRxiv(2022)10.1101/2022.06.19.22276599

N/A

0.241DataRank · unranked

4 citations

Naomi J. Patel, Xiaosong Wang, Claire Cook, Kathleen M.M. Vanni, Emily Kowalski +9 more

OP0286 CHARACTERISTICS ASSOCIATED WITH SEVERE COVID-19 OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE (COVID-19 GRA)

Annals of the Rheumatic Diseases(2021)10.1136/annrheumdis-2021-eular.2984

N/A

0DataRank · unranked

1 citations

G S Alarcón, Andrea M. Seet, Zara Izadi, C. Reategui Sokolova, Ann E. Clarke +45 more

Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases

medRxiv(2021)10.1101/2021.08.04.21261618

N/A

0DataRank · unranked

9 citations

Naomi J. Patel, Kristin M. D’Silva, Tiffany Hsu, Michael DiIorio, Lauren Prisco +7 more

Response to: ‘Correspondence on ‘SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease’’ by C et al

Annals of the Rheumatic Diseases(2021)10.1136/annrheumdis-2021-220166

N/A

0DataRank · unranked

7 citations

Naomi Serling‐Boyd, Tiffany Hsu, Jeffrey A. Sparks, Zachary S. Wallace, Kristin M. D’Silva

OP0006 ASSOCIATIONS OF BASELINE USE OF BIOLOGIC OR TARGETED SYNTHETIC DMARDS WITH COVID-19 SEVERITY IN RHEUMATOID ARTHRITIS: RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE

Annals of the Rheumatic Diseases(2021)10.1136/annrheumdis-2021-eular.1632

N/A

0DataRank · unranked

4 citations

Zachary S. Wallace, Andrea M. Seet, Milena Gianfrancesco, Zara Izadi, Kimme L Hyrich +37 more

SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease

Annals of the Rheumatic Diseases(2021)10.1136/annrheumdis-2020-219808

N/A

0DataRank · unranked

39 citations

Naomi Serling‐Boyd, Tiffany Hsu, Jeffrey A. Sparks, Zachary S. Wallace, Kristin M. D’Silva

DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study

Seminars in Arthritis and Rheumatism(2022)10.1016/j.semarthrit.2022.152025

N/A

0DataRank · unranked

67 citations

Claire Cook, Kathleen M.M. Vanni, Naomi J. Patel, Kristin M. D’Silva, Xiaoqing Fu +10 more

Deletion of immune evasion genes provides an effective vaccine design for tumor-associated herpesviruses

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.13.034082

N/A

0DataRank · unranked

0 citations

Nisar Farhat, Alisa Sukhina, Alex K. Lam, Yong‐Hoon Kim, Tiffany Hsu +7 more

Response to: ‘COVID-19 in patients with rheumatic diseases: what is the real mortality risk?‘ by Marques et al

Annals of the Rheumatic Diseases(2020)10.1136/annrheumdis-2020-218431

N/A

0DataRank · unranked

3 citations

Naomi Serling‐Boyd, Rachel Wallwork, Tiffany Hsu, Jeffrey A. Sparks, Zachary S. Wallace +1 more

Assessing the Severity of COVID‐19 Lung Injury in Rheumatic Diseases Versus the General Population Using Deep Learning–Derived Chest Radiograph Scores

Arthritis Care & Research(2022)10.1002/acr.24883

N/A

0DataRank · unranked

8 citations

Kristin M. D’Silva, Matthew Li, Tiffany Hsu, Michael DiIorio, Xiaoqing Fu +10 more

Deletion of immune evasion genes provides an effective vaccine design for tumor-associated herpesviruses

npj Vaccines(2020)10.1038/s41541-020-00251-x

N/A

0DataRank · unranked

23 citations

Nisar Farhat, Alisa Sukhina, Alex K. Lam, Yong‐Hoon Kim, Tiffany Hsu +7 more

Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic

Annals of the Rheumatic Diseases(2020)10.1136/annrheumdis-2020-219279

N/A

0DataRank · unranked

95 citations

Kristin M. D’Silva, Tiffany Hsu, Rachel Wallwork, Xiaoqing Fu, Ellen M. Gravallese +6 more